Global Gastrointestinal Cancer Drugs Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
Page: 108
Published Date: 06 Jan 2024
Category: Pharma & Healthcare
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Description
According to our (Global Info Research) latest study, the global Gastrointestinal Cancer Drugs market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
Gastrointestinal cancer is the abnormal condition of the gastrointestinal tract and associated organs of digestive system, which comprises esophagus, stomach, pancreas, biliary system, small intestine, large intestine, rectum, and anus. The symptoms of gastrointestinal cancer depend on the affected organ, and include obstruction (resulting in difficulty to swallow or excrete), unusual bleeding, or other related problems.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Gastrointestinal Cancer Drugs industry chain, the market status of Hospitals (Oncology, Radiology), Specialized Cancer Treatment Centers (Oncology, Radiology), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Gastrointestinal Cancer Drugs.
Regionally, the report analyzes the Gastrointestinal Cancer Drugs markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Gastrointestinal Cancer Drugs market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Gastrointestinal Cancer Drugs market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Gastrointestinal Cancer Drugs industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (g), revenue generated, and market share of different by Type (e.g., Oncology, Radiology).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Gastrointestinal Cancer Drugs market.
Regional Analysis: The report involves examining the Gastrointestinal Cancer Drugs market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Gastrointestinal Cancer Drugs market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Gastrointestinal Cancer Drugs:
Company Analysis: Report covers individual Gastrointestinal Cancer Drugs manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Gastrointestinal Cancer Drugs This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospitals, Specialized Cancer Treatment Centers).
Technology Analysis: Report covers specific technologies relevant to Gastrointestinal Cancer Drugs. It assesses the current state, advancements, and potential future developments in Gastrointestinal Cancer Drugs areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Gastrointestinal Cancer Drugs market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Gastrointestinal Cancer Drugs market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Oncology
Radiology
Others
Market segment by Application
Hospitals
Specialized Cancer Treatment Centers
Clinics
Ambulatory Surgical Centers
Major players covered
Amgen & Amgen Ireland
Bristol-Myers Squibb Company
Roche
Eli Lilly and Company
Johnson & Johnson Private
GlaxoSmithKline
Celgene Corporation
Pfizer
Sanofi
Novartis
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Gastrointestinal Cancer Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Gastrointestinal Cancer Drugs, with price, sales, revenue and global market share of Gastrointestinal Cancer Drugs from 2019 to 2024.
Chapter 3, the Gastrointestinal Cancer Drugs competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Gastrointestinal Cancer Drugs breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Gastrointestinal Cancer Drugs market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Gastrointestinal Cancer Drugs.
Chapter 14 and 15, to describe Gastrointestinal Cancer Drugs sales channel, distributors, customers, research findings and conclusion.
Table of Contents
1 Market Overview
1.1 Product Overview and Scope of Gastrointestinal Cancer Drugs
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Gastrointestinal Cancer Drugs Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Oncology
1.3.3 Radiology
1.3.4 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Gastrointestinal Cancer Drugs Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospitals
1.4.3 Specialized Cancer Treatment Centers
1.4.4 Clinics
1.4.5 Ambulatory Surgical Centers
1.5 Global Gastrointestinal Cancer Drugs Market Size & Forecast
1.5.1 Global Gastrointestinal Cancer Drugs Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Gastrointestinal Cancer Drugs Sales Quantity (2019-2030)
1.5.3 Global Gastrointestinal Cancer Drugs Average Price (2019-2030)
2.1 Amgen & Amgen Ireland
2.1.1 Amgen & Amgen Ireland Details
2.1.2 Amgen & Amgen Ireland Major Business
2.1.3 Amgen & Amgen Ireland Gastrointestinal Cancer Drugs Product and Services
2.1.4 Amgen & Amgen Ireland Gastrointestinal Cancer Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Amgen & Amgen Ireland Recent Developments/Updates
2.2 Bristol-Myers Squibb Company
2.2.1 Bristol-Myers Squibb Company Details
2.2.2 Bristol-Myers Squibb Company Major Business
2.2.3 Bristol-Myers Squibb Company Gastrointestinal Cancer Drugs Product and Services
2.2.4 Bristol-Myers Squibb Company Gastrointestinal Cancer Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Bristol-Myers Squibb Company Recent Developments/Updates
2.3 Roche
2.3.1 Roche Details
2.3.2 Roche Major Business
2.3.3 Roche Gastrointestinal Cancer Drugs Product and Services
2.3.4 Roche Gastrointestinal Cancer Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Roche Recent Developments/Updates
2.4 Eli Lilly and Company
2.4.1 Eli Lilly and Company Details
2.4.2 Eli Lilly and Company Major Business
2.4.3 Eli Lilly and Company Gastrointestinal Cancer Drugs Product and Services
2.4.4 Eli Lilly and Company Gastrointestinal Cancer Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Eli Lilly and Company Recent Developments/Updates
2.5 Johnson & Johnson Private
2.5.1 Johnson & Johnson Private Details
2.5.2 Johnson & Johnson Private Major Business
2.5.3 Johnson & Johnson Private Gastrointestinal Cancer Drugs Product and Services
2.5.4 Johnson & Johnson Private Gastrointestinal Cancer Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Johnson & Johnson Private Recent Developments/Updates
2.6 GlaxoSmithKline
2.6.1 GlaxoSmithKline Details
2.6.2 GlaxoSmithKline Major Business
2.6.3 GlaxoSmithKline Gastrointestinal Cancer Drugs Product and Services
2.6.4 GlaxoSmithKline Gastrointestinal Cancer Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 GlaxoSmithKline Recent Developments/Updates
2.7 Celgene Corporation
2.7.1 Celgene Corporation Details
2.7.2 Celgene Corporation Major Business
2.7.3 Celgene Corporation Gastrointestinal Cancer Drugs Product and Services
2.7.4 Celgene Corporation Gastrointestinal Cancer Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Celgene Corporation Recent Developments/Updates
2.8 Pfizer
2.8.1 Pfizer Details
2.8.2 Pfizer Major Business
2.8.3 Pfizer Gastrointestinal Cancer Drugs Product and Services
2.8.4 Pfizer Gastrointestinal Cancer Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Pfizer Recent Developments/Updates
2.9 Sanofi
2.9.1 Sanofi Details
2.9.2 Sanofi Major Business
2.9.3 Sanofi Gastrointestinal Cancer Drugs Product and Services
2.9.4 Sanofi Gastrointestinal Cancer Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Sanofi Recent Developments/Updates
2.10 Novartis
2.10.1 Novartis Details
2.10.2 Novartis Major Business
2.10.3 Novartis Gastrointestinal Cancer Drugs Product and Services
2.10.4 Novartis Gastrointestinal Cancer Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Novartis Recent Developments/Updates
3.1 Global Gastrointestinal Cancer Drugs Sales Quantity by Manufacturer (2019-2024)
3.2 Global Gastrointestinal Cancer Drugs Revenue by Manufacturer (2019-2024)
3.3 Global Gastrointestinal Cancer Drugs Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Gastrointestinal Cancer Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Gastrointestinal Cancer Drugs Manufacturer Market Share in 2023
3.4.2 Top 6 Gastrointestinal Cancer Drugs Manufacturer Market Share in 2023
3.5 Gastrointestinal Cancer Drugs Market: Overall Company Footprint Analysis
3.5.1 Gastrointestinal Cancer Drugs Market: Region Footprint
3.5.2 Gastrointestinal Cancer Drugs Market: Company Product Type Footprint
3.5.3 Gastrointestinal Cancer Drugs Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4.1 Global Gastrointestinal Cancer Drugs Market Size by Region
4.1.1 Global Gastrointestinal Cancer Drugs Sales Quantity by Region (2019-2030)
4.1.2 Global Gastrointestinal Cancer Drugs Consumption Value by Region (2019-2030)
4.1.3 Global Gastrointestinal Cancer Drugs Average Price by Region (2019-2030)
4.2 North America Gastrointestinal Cancer Drugs Consumption Value (2019-2030)
4.3 Europe Gastrointestinal Cancer Drugs Consumption Value (2019-2030)
4.4 Asia-Pacific Gastrointestinal Cancer Drugs Consumption Value (2019-2030)
4.5 South America Gastrointestinal Cancer Drugs Consumption Value (2019-2030)
4.6 Middle East and Africa Gastrointestinal Cancer Drugs Consumption Value (2019-2030)
5.1 Global Gastrointestinal Cancer Drugs Sales Quantity by Type (2019-2030)
5.2 Global Gastrointestinal Cancer Drugs Consumption Value by Type (2019-2030)
5.3 Global Gastrointestinal Cancer Drugs Average Price by Type (2019-2030)
6.1 Global Gastrointestinal Cancer Drugs Sales Quantity by Application (2019-2030)
6.2 Global Gastrointestinal Cancer Drugs Consumption Value by Application (2019-2030)
6.3 Global Gastrointestinal Cancer Drugs Average Price by Application (2019-2030)
7.1 North America Gastrointestinal Cancer Drugs Sales Quantity by Type (2019-2030)
7.2 North America Gastrointestinal Cancer Drugs Sales Quantity by Application (2019-2030)
7.3 North America Gastrointestinal Cancer Drugs Market Size by Country
7.3.1 North America Gastrointestinal Cancer Drugs Sales Quantity by Country (2019-2030)
7.3.2 North America Gastrointestinal Cancer Drugs Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8.1 Europe Gastrointestinal Cancer Drugs Sales Quantity by Type (2019-2030)
8.2 Europe Gastrointestinal Cancer Drugs Sales Quantity by Application (2019-2030)
8.3 Europe Gastrointestinal Cancer Drugs Market Size by Country
8.3.1 Europe Gastrointestinal Cancer Drugs Sales Quantity by Country (2019-2030)
8.3.2 Europe Gastrointestinal Cancer Drugs Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9.1 Asia-Pacific Gastrointestinal Cancer Drugs Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Gastrointestinal Cancer Drugs Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Gastrointestinal Cancer Drugs Market Size by Region
9.3.1 Asia-Pacific Gastrointestinal Cancer Drugs Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Gastrointestinal Cancer Drugs Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10.1 South America Gastrointestinal Cancer Drugs Sales Quantity by Type (2019-2030)
10.2 South America Gastrointestinal Cancer Drugs Sales Quantity by Application (2019-2030)
10.3 South America Gastrointestinal Cancer Drugs Market Size by Country
10.3.1 South America Gastrointestinal Cancer Drugs Sales Quantity by Country (2019-2030)
10.3.2 South America Gastrointestinal Cancer Drugs Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11.1 Middle East & Africa Gastrointestinal Cancer Drugs Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Gastrointestinal Cancer Drugs Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Gastrointestinal Cancer Drugs Market Size by Country
11.3.1 Middle East & Africa Gastrointestinal Cancer Drugs Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Gastrointestinal Cancer Drugs Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12.1 Gastrointestinal Cancer Drugs Market Drivers
12.2 Gastrointestinal Cancer Drugs Market Restraints
12.3 Gastrointestinal Cancer Drugs Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13.1 Raw Material of Gastrointestinal Cancer Drugs and Key Manufacturers
13.2 Manufacturing Costs Percentage of Gastrointestinal Cancer Drugs
13.3 Gastrointestinal Cancer Drugs Production Process
13.4 Gastrointestinal Cancer Drugs Industrial Chain
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Gastrointestinal Cancer Drugs Typical Distributors
14.3 Gastrointestinal Cancer Drugs Typical Customers
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Table of Figures
List of Tables
Table 1. Global Gastrointestinal Cancer Drugs Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Gastrointestinal Cancer Drugs Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Amgen & Amgen Ireland Basic Information, Manufacturing Base and Competitors
Table 4. Amgen & Amgen Ireland Major Business
Table 5. Amgen & Amgen Ireland Gastrointestinal Cancer Drugs Product and Services
Table 6. Amgen & Amgen Ireland Gastrointestinal Cancer Drugs Sales Quantity (g), Average Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Amgen & Amgen Ireland Recent Developments/Updates
Table 8. Bristol-Myers Squibb Company Basic Information, Manufacturing Base and Competitors
Table 9. Bristol-Myers Squibb Company Major Business
Table 10. Bristol-Myers Squibb Company Gastrointestinal Cancer Drugs Product and Services
Table 11. Bristol-Myers Squibb Company Gastrointestinal Cancer Drugs Sales Quantity (g), Average Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Bristol-Myers Squibb Company Recent Developments/Updates
Table 13. Roche Basic Information, Manufacturing Base and Competitors
Table 14. Roche Major Business
Table 15. Roche Gastrointestinal Cancer Drugs Product and Services
Table 16. Roche Gastrointestinal Cancer Drugs Sales Quantity (g), Average Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Roche Recent Developments/Updates
Table 18. Eli Lilly and Company Basic Information, Manufacturing Base and Competitors
Table 19. Eli Lilly and Company Major Business
Table 20. Eli Lilly and Company Gastrointestinal Cancer Drugs Product and Services
Table 21. Eli Lilly and Company Gastrointestinal Cancer Drugs Sales Quantity (g), Average Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Eli Lilly and Company Recent Developments/Updates
Table 23. Johnson & Johnson Private Basic Information, Manufacturing Base and Competitors
Table 24. Johnson & Johnson Private Major Business
Table 25. Johnson & Johnson Private Gastrointestinal Cancer Drugs Product and Services
Table 26. Johnson & Johnson Private Gastrointestinal Cancer Drugs Sales Quantity (g), Average Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Johnson & Johnson Private Recent Developments/Updates
Table 28. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 29. GlaxoSmithKline Major Business
Table 30. GlaxoSmithKline Gastrointestinal Cancer Drugs Product and Services
Table 31. GlaxoSmithKline Gastrointestinal Cancer Drugs Sales Quantity (g), Average Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. GlaxoSmithKline Recent Developments/Updates
Table 33. Celgene Corporation Basic Information, Manufacturing Base and Competitors
Table 34. Celgene Corporation Major Business
Table 35. Celgene Corporation Gastrointestinal Cancer Drugs Product and Services
Table 36. Celgene Corporation Gastrointestinal Cancer Drugs Sales Quantity (g), Average Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. Celgene Corporation Recent Developments/Updates
Table 38. Pfizer Basic Information, Manufacturing Base and Competitors
Table 39. Pfizer Major Business
Table 40. Pfizer Gastrointestinal Cancer Drugs Product and Services
Table 41. Pfizer Gastrointestinal Cancer Drugs Sales Quantity (g), Average Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. Pfizer Recent Developments/Updates
Table 43. Sanofi Basic Information, Manufacturing Base and Competitors
Table 44. Sanofi Major Business
Table 45. Sanofi Gastrointestinal Cancer Drugs Product and Services
Table 46. Sanofi Gastrointestinal Cancer Drugs Sales Quantity (g), Average Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. Sanofi Recent Developments/Updates
Table 48. Novartis Basic Information, Manufacturing Base and Competitors
Table 49. Novartis Major Business
Table 50. Novartis Gastrointestinal Cancer Drugs Product and Services
Table 51. Novartis Gastrointestinal Cancer Drugs Sales Quantity (g), Average Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 52. Novartis Recent Developments/Updates
Table 53. Global Gastrointestinal Cancer Drugs Sales Quantity by Manufacturer (2019-2024) & (g)
Table 54. Global Gastrointestinal Cancer Drugs Revenue by Manufacturer (2019-2024) & (USD Million)
Table 55. Global Gastrointestinal Cancer Drugs Average Price by Manufacturer (2019-2024) & (USD/g)
Table 56. Market Position of Manufacturers in Gastrointestinal Cancer Drugs, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 57. Head Office and Gastrointestinal Cancer Drugs Production Site of Key Manufacturer
Table 58. Gastrointestinal Cancer Drugs Market: Company Product Type Footprint
Table 59. Gastrointestinal Cancer Drugs Market: Company Product Application Footprint
Table 60. Gastrointestinal Cancer Drugs New Market Entrants and Barriers to Market Entry
Table 61. Gastrointestinal Cancer Drugs Mergers, Acquisition, Agreements, and Collaborations
Table 62. Global Gastrointestinal Cancer Drugs Sales Quantity by Region (2019-2024) & (g)
Table 63. Global Gastrointestinal Cancer Drugs Sales Quantity by Region (2025-2030) & (g)
Table 64. Global Gastrointestinal Cancer Drugs Consumption Value by Region (2019-2024) & (USD Million)
Table 65. Global Gastrointestinal Cancer Drugs Consumption Value by Region (2025-2030) & (USD Million)
Table 66. Global Gastrointestinal Cancer Drugs Average Price by Region (2019-2024) & (USD/g)
Table 67. Global Gastrointestinal Cancer Drugs Average Price by Region (2025-2030) & (USD/g)
Table 68. Global Gastrointestinal Cancer Drugs Sales Quantity by Type (2019-2024) & (g)
Table 69. Global Gastrointestinal Cancer Drugs Sales Quantity by Type (2025-2030) & (g)
Table 70. Global Gastrointestinal Cancer Drugs Consumption Value by Type (2019-2024) & (USD Million)
Table 71. Global Gastrointestinal Cancer Drugs Consumption Value by Type (2025-2030) & (USD Million)
Table 72. Global Gastrointestinal Cancer Drugs Average Price by Type (2019-2024) & (USD/g)
Table 73. Global Gastrointestinal Cancer Drugs Average Price by Type (2025-2030) & (USD/g)
Table 74. Global Gastrointestinal Cancer Drugs Sales Quantity by Application (2019-2024) & (g)
Table 75. Global Gastrointestinal Cancer Drugs Sales Quantity by Application (2025-2030) & (g)
Table 76. Global Gastrointestinal Cancer Drugs Consumption Value by Application (2019-2024) & (USD Million)
Table 77. Global Gastrointestinal Cancer Drugs Consumption Value by Application (2025-2030) & (USD Million)
Table 78. Global Gastrointestinal Cancer Drugs Average Price by Application (2019-2024) & (USD/g)
Table 79. Global Gastrointestinal Cancer Drugs Average Price by Application (2025-2030) & (USD/g)
Table 80. North America Gastrointestinal Cancer Drugs Sales Quantity by Type (2019-2024) & (g)
Table 81. North America Gastrointestinal Cancer Drugs Sales Quantity by Type (2025-2030) & (g)
Table 82. North America Gastrointestinal Cancer Drugs Sales Quantity by Application (2019-2024) & (g)
Table 83. North America Gastrointestinal Cancer Drugs Sales Quantity by Application (2025-2030) & (g)
Table 84. North America Gastrointestinal Cancer Drugs Sales Quantity by Country (2019-2024) & (g)
Table 85. North America Gastrointestinal Cancer Drugs Sales Quantity by Country (2025-2030) & (g)
Table 86. North America Gastrointestinal Cancer Drugs Consumption Value by Country (2019-2024) & (USD Million)
Table 87. North America Gastrointestinal Cancer Drugs Consumption Value by Country (2025-2030) & (USD Million)
Table 88. Europe Gastrointestinal Cancer Drugs Sales Quantity by Type (2019-2024) & (g)
Table 89. Europe Gastrointestinal Cancer Drugs Sales Quantity by Type (2025-2030) & (g)
Table 90. Europe Gastrointestinal Cancer Drugs Sales Quantity by Application (2019-2024) & (g)
Table 91. Europe Gastrointestinal Cancer Drugs Sales Quantity by Application (2025-2030) & (g)
Table 92. Europe Gastrointestinal Cancer Drugs Sales Quantity by Country (2019-2024) & (g)
Table 93. Europe Gastrointestinal Cancer Drugs Sales Quantity by Country (2025-2030) & (g)
Table 94. Europe Gastrointestinal Cancer Drugs Consumption Value by Country (2019-2024) & (USD Million)
Table 95. Europe Gastrointestinal Cancer Drugs Consumption Value by Country (2025-2030) & (USD Million)
Table 96. Asia-Pacific Gastrointestinal Cancer Drugs Sales Quantity by Type (2019-2024) & (g)
Table 97. Asia-Pacific Gastrointestinal Cancer Drugs Sales Quantity by Type (2025-2030) & (g)
Table 98. Asia-Pacific Gastrointestinal Cancer Drugs Sales Quantity by Application (2019-2024) & (g)
Table 99. Asia-Pacific Gastrointestinal Cancer Drugs Sales Quantity by Application (2025-2030) & (g)
Table 100. Asia-Pacific Gastrointestinal Cancer Drugs Sales Quantity by Region (2019-2024) & (g)
Table 101. Asia-Pacific Gastrointestinal Cancer Drugs Sales Quantity by Region (2025-2030) & (g)
Table 102. Asia-Pacific Gastrointestinal Cancer Drugs Consumption Value by Region (2019-2024) & (USD Million)
Table 103. Asia-Pacific Gastrointestinal Cancer Drugs Consumption Value by Region (2025-2030) & (USD Million)
Table 104. South America Gastrointestinal Cancer Drugs Sales Quantity by Type (2019-2024) & (g)
Table 105. South America Gastrointestinal Cancer Drugs Sales Quantity by Type (2025-2030) & (g)
Table 106. South America Gastrointestinal Cancer Drugs Sales Quantity by Application (2019-2024) & (g)
Table 107. South America Gastrointestinal Cancer Drugs Sales Quantity by Application (2025-2030) & (g)
Table 108. South America Gastrointestinal Cancer Drugs Sales Quantity by Country (2019-2024) & (g)
Table 109. South America Gastrointestinal Cancer Drugs Sales Quantity by Country (2025-2030) & (g)
Table 110. South America Gastrointestinal Cancer Drugs Consumption Value by Country (2019-2024) & (USD Million)
Table 111. South America Gastrointestinal Cancer Drugs Consumption Value by Country (2025-2030) & (USD Million)
Table 112. Middle East & Africa Gastrointestinal Cancer Drugs Sales Quantity by Type (2019-2024) & (g)
Table 113. Middle East & Africa Gastrointestinal Cancer Drugs Sales Quantity by Type (2025-2030) & (g)
Table 114. Middle East & Africa Gastrointestinal Cancer Drugs Sales Quantity by Application (2019-2024) & (g)
Table 115. Middle East & Africa Gastrointestinal Cancer Drugs Sales Quantity by Application (2025-2030) & (g)
Table 116. Middle East & Africa Gastrointestinal Cancer Drugs Sales Quantity by Region (2019-2024) & (g)
Table 117. Middle East & Africa Gastrointestinal Cancer Drugs Sales Quantity by Region (2025-2030) & (g)
Table 118. Middle East & Africa Gastrointestinal Cancer Drugs Consumption Value by Region (2019-2024) & (USD Million)
Table 119. Middle East & Africa Gastrointestinal Cancer Drugs Consumption Value by Region (2025-2030) & (USD Million)
Table 120. Gastrointestinal Cancer Drugs Raw Material
Table 121. Key Manufacturers of Gastrointestinal Cancer Drugs Raw Materials
Table 122. Gastrointestinal Cancer Drugs Typical Distributors
Table 123. Gastrointestinal Cancer Drugs Typical Customers
List of Figures
Figure 1. Gastrointestinal Cancer Drugs Picture
Figure 2. Global Gastrointestinal Cancer Drugs Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Gastrointestinal Cancer Drugs Consumption Value Market Share by Type in 2023
Figure 4. Oncology Examples
Figure 5. Radiology Examples
Figure 6. Others Examples
Figure 7. Global Gastrointestinal Cancer Drugs Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 8. Global Gastrointestinal Cancer Drugs Consumption Value Market Share by Application in 2023
Figure 9. Hospitals Examples
Figure 10. Specialized Cancer Treatment Centers Examples
Figure 11. Clinics Examples
Figure 12. Ambulatory Surgical Centers Examples
Figure 13. Global Gastrointestinal Cancer Drugs Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 14. Global Gastrointestinal Cancer Drugs Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 15. Global Gastrointestinal Cancer Drugs Sales Quantity (2019-2030) & (g)
Figure 16. Global Gastrointestinal Cancer Drugs Average Price (2019-2030) & (USD/g)
Figure 17. Global Gastrointestinal Cancer Drugs Sales Quantity Market Share by Manufacturer in 2023
Figure 18. Global Gastrointestinal Cancer Drugs Consumption Value Market Share by Manufacturer in 2023
Figure 19. Producer Shipments of Gastrointestinal Cancer Drugs by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 20. Top 3 Gastrointestinal Cancer Drugs Manufacturer (Consumption Value) Market Share in 2023
Figure 21. Top 6 Gastrointestinal Cancer Drugs Manufacturer (Consumption Value) Market Share in 2023
Figure 22. Global Gastrointestinal Cancer Drugs Sales Quantity Market Share by Region (2019-2030)
Figure 23. Global Gastrointestinal Cancer Drugs Consumption Value Market Share by Region (2019-2030)
Figure 24. North America Gastrointestinal Cancer Drugs Consumption Value (2019-2030) & (USD Million)
Figure 25. Europe Gastrointestinal Cancer Drugs Consumption Value (2019-2030) & (USD Million)
Figure 26. Asia-Pacific Gastrointestinal Cancer Drugs Consumption Value (2019-2030) & (USD Million)
Figure 27. South America Gastrointestinal Cancer Drugs Consumption Value (2019-2030) & (USD Million)
Figure 28. Middle East & Africa Gastrointestinal Cancer Drugs Consumption Value (2019-2030) & (USD Million)
Figure 29. Global Gastrointestinal Cancer Drugs Sales Quantity Market Share by Type (2019-2030)
Figure 30. Global Gastrointestinal Cancer Drugs Consumption Value Market Share by Type (2019-2030)
Figure 31. Global Gastrointestinal Cancer Drugs Average Price by Type (2019-2030) & (USD/g)
Figure 32. Global Gastrointestinal Cancer Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 33. Global Gastrointestinal Cancer Drugs Consumption Value Market Share by Application (2019-2030)
Figure 34. Global Gastrointestinal Cancer Drugs Average Price by Application (2019-2030) & (USD/g)
Figure 35. North America Gastrointestinal Cancer Drugs Sales Quantity Market Share by Type (2019-2030)
Figure 36. North America Gastrointestinal Cancer Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 37. North America Gastrointestinal Cancer Drugs Sales Quantity Market Share by Country (2019-2030)
Figure 38. North America Gastrointestinal Cancer Drugs Consumption Value Market Share by Country (2019-2030)
Figure 39. United States Gastrointestinal Cancer Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 40. Canada Gastrointestinal Cancer Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 41. Mexico Gastrointestinal Cancer Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 42. Europe Gastrointestinal Cancer Drugs Sales Quantity Market Share by Type (2019-2030)
Figure 43. Europe Gastrointestinal Cancer Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 44. Europe Gastrointestinal Cancer Drugs Sales Quantity Market Share by Country (2019-2030)
Figure 45. Europe Gastrointestinal Cancer Drugs Consumption Value Market Share by Country (2019-2030)
Figure 46. Germany Gastrointestinal Cancer Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 47. France Gastrointestinal Cancer Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. United Kingdom Gastrointestinal Cancer Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 49. Russia Gastrointestinal Cancer Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 50. Italy Gastrointestinal Cancer Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 51. Asia-Pacific Gastrointestinal Cancer Drugs Sales Quantity Market Share by Type (2019-2030)
Figure 52. Asia-Pacific Gastrointestinal Cancer Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 53. Asia-Pacific Gastrointestinal Cancer Drugs Sales Quantity Market Share by Region (2019-2030)
Figure 54. Asia-Pacific Gastrointestinal Cancer Drugs Consumption Value Market Share by Region (2019-2030)
Figure 55. China Gastrointestinal Cancer Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 56. Japan Gastrointestinal Cancer Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. Korea Gastrointestinal Cancer Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. India Gastrointestinal Cancer Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. Southeast Asia Gastrointestinal Cancer Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 60. Australia Gastrointestinal Cancer Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 61. South America Gastrointestinal Cancer Drugs Sales Quantity Market Share by Type (2019-2030)
Figure 62. South America Gastrointestinal Cancer Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 63. South America Gastrointestinal Cancer Drugs Sales Quantity Market Share by Country (2019-2030)
Figure 64. South America Gastrointestinal Cancer Drugs Consumption Value Market Share by Country (2019-2030)
Figure 65. Brazil Gastrointestinal Cancer Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 66. Argentina Gastrointestinal Cancer Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 67. Middle East & Africa Gastrointestinal Cancer Drugs Sales Quantity Market Share by Type (2019-2030)
Figure 68. Middle East & Africa Gastrointestinal Cancer Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 69. Middle East & Africa Gastrointestinal Cancer Drugs Sales Quantity Market Share by Region (2019-2030)
Figure 70. Middle East & Africa Gastrointestinal Cancer Drugs Consumption Value Market Share by Region (2019-2030)
Figure 71. Turkey Gastrointestinal Cancer Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 72. Egypt Gastrointestinal Cancer Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 73. Saudi Arabia Gastrointestinal Cancer Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 74. South Africa Gastrointestinal Cancer Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 75. Gastrointestinal Cancer Drugs Market Drivers
Figure 76. Gastrointestinal Cancer Drugs Market Restraints
Figure 77. Gastrointestinal Cancer Drugs Market Trends
Figure 78. Porters Five Forces Analysis
Figure 79. Manufacturing Cost Structure Analysis of Gastrointestinal Cancer Drugs in 2023
Figure 80. Manufacturing Process Analysis of Gastrointestinal Cancer Drugs
Figure 81. Gastrointestinal Cancer Drugs Industrial Chain
Figure 82. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 83. Direct Channel Pros & Cons
Figure 84. Indirect Channel Pros & Cons
Figure 85. Methodology
Figure 86. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
Amgen & Amgen Ireland Bristol-Myers Squibb Company Roche Eli Lilly and Company Johnson & Johnson Private GlaxoSmithKline Celgene Corporation Pfizer Sanofi Novartis
01 Feb 2023
Pharma & Healthcare
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
